Steven Cohen Ptc Therapeutics, Inc. Call Options Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
Call Options
3 transactions
Others Institutions Holding PTCT
# of Institutions
223Shares Held
79.3MCall Options Held
122KPut Options Held
207K-
Vanguard Group Inc Valley Forge, PA8.97MShares$397 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.21MShares$363 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$344 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$327 Million3.78% of portfolio
-
Armistice Capital, LLC New York, NY6.96MShares$308 Million2.77% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.17B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...